
Angelini Chemicals
-
-
Since 1967 into API CDMO business
-
We help to make your Molecules
-
Put your chemistry in our hands
News & publications
-
Pubblicato:
Refocus and restart of the pharmaceutical supply chain
The Supply Chain refers to the entire network of entities, resources, activities, and technologies involved in the creation and sale of a product, from the sourcing of starting materials from the supplier to the manufacturer, through to its eventual delivery to the end user. Just-in-time has been, for a long time, the most successful supply chain model for maximizing efficiency. But, currently, it’s no longer the best.
-
Pubblicato:
Biotech Outsourcing Strategies
BOS Basel 2025's scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics and also covering Novel Therapeutic Entities.
-
Pubblicato:
Celebrating six years of excellence: Angelini Pharma ranked among Europe's Top 10 employers for 2025
Angelini Pharma has been awarded the prestigious Top Employer certification for the sixth consecutive year.
-
Pubblicato:
PHARMA 4.0: Race to digitalization
Digitalization in the pharmaceutical industry refers to the integration and adoption of digital technologies to fundamentally change how companies operate, deliver value, and interact with stakeholders. It goes beyond individual technology implementations and is related to a re-design of business processes, organizational culture, and customer experiences.
-
Pubblicato:
Sustainability: exploring its significance at Angelini Pharma
Sustainability has been a frequently mentioned concept over the last few years across many manufacturing platforms but more recently has become a popular topic within the pharmaceutical industry.
-
Pubblicato:
Green API manufacturing
As generic competition increases it is crucial to examine different ways to improve efficiency and cost reduction in the manufacturing process for the active pharmaceutical ingredient (API).
-
Pubblicato:
CFRT
CFRT is the prime international event to learn about the latest innovation and technologies related to the field of flow chemistry and continuous manufacturing.
-
Pubblicato:
CPHI Worldwide 2025
CPHI Frankfurt is the most important pharmaceutical event worldwide and represents each stage of the pharmaceutical supply chain.
-
Pubblicato:
CDMO - CRDMO: tools and different business model for new opportunity in synthesis
The active pharmaceutical ingredient (API) is the foundation of a final drug product and is a crucial consideration when choosing a Contract Development and Manufacturing Organisation (CDMO) or Contract Research (in House) Development and Manufacturing Organisation (CRDMO).
-
Pubblicato:
Impact of Covid-19 on global pharmaceutical production and trade
Drugs & APIs shortage is a global issue with an evident impact affecting all the people independently of their geographic or economic position.
-
Pubblicato:
An overview of the US pharma landscape
Over the past 10+ years the pharmaceutical Industry has utilized CDMO’s at an increasing level from year to year never seen prior to this period...
-
Pubblicato:
“CRDMO” the new business model for future of the (Bio)Pharma Industry
Today CDMOs face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm...
-
Pubblicato:
Angelini Pharma continues its commitment to HPAPI services
Facing the rising number of custom HPAPIs demand, Angelini Fine Chemicals decided to expand its HPAPI capacity at its Aprilia,Italy plant site
-
Pubblicato:
Flow Chemistry as novel chirotechnologic tool for asymmetric synthesis of APIs
The continuous-flow enantioselective processes have to be seen as a pivot point for sustainable development of the tomorrow’s pharmaceutical industry
-
Pubblicato:
Modern and future strategic trends of the pharma outsourcing market
Today Contract Development Manufacturing Organizations (CDMOs) face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm